A woman with stage three lung cancer is trying to fund private treatment after being told by the NHS it can only offer ...

Physicians at Health Hospital are diagnosing lung cancer earlier after the hospital recently implemented 3D technology to support its robotic lung biopsy systems. By using robotic biopsy systems ...

Lung cancer remains the leading cause of cancer-related death in the United States. The good news is that early detection ...

Researchers have developed a way to predict how lung cancer cells will respond to different therapies, allowing people with ...

A new study led by researchers at Wake Forest University School of Medicine, in collaboration with the University of North Carolina at Chapel Hill and MD Anderson Cancer Center, has found that a ...

Race and economic disparities significantly affect lung cancer treatment and outcomes with worse outcomes seen in Black and ...

Trodelvy reduced progression or death risk by 51% compared to chemotherapy in EGFR-mutated non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors. The median progression-free survival ...

Alectinib showed a 22% reduction in death risk compared to crizotinib in advanced ALK-positive NSCLC, with a median OS of 81.1 months versus 54.2 months. Significant OS benefits were observed in ...

Saxon Gayo, 60, a lung cancer survivor, shared his story during a proclamation signing at Adelup on Friday, advocating for ...

In May, Summit released early data from the Phase III HARMONi study showing that while the PD-1/VEGF inhibitor resulted in ...